News: Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

109.40CHF
30 Mar 2015
Change (% chg)

CHF1.40 (+1.30%)
Prev Close
CHF108.00
Open
CHF109.40
Day's High
CHF109.40
Day's Low
CHF109.40
Volume
1,456
Avg. Vol
98,222
52-wk High
CHF125.50
52-wk Low
CHF79.75

Search Stocks
Select another date:

Tue, Feb 17 2015

BRIEF-Basilea Pharmaceutica says Swissmedic approves Zevtera

* Says Swissmedic approves Basilea's antibiotic Zevtera (ceftobiprole medocaril) for treatment of pneumonia

BRIEF-Basilea Pharmaceutica announces launch of antibiotic Zevtera in Germany

* Announces launch of antibiotic Zevtera (ceftobiprole medocaril) in Germany Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Basilea Pharmaceutica gets U.S. orphan drug designation for isavuconazole for treatment of invasive candidiasis

* Reports granting of U.S. orphan drug designation to isavuconazole for the treatment of invasive candidiasis

BRIEF-Basilea Pharmaceutica reports protocol amendment resulting in earlier completion of isavuconazole phase 3 invasive candidiasis study

* Reports protocol amendment resulting in earlier completion of isavuconazole phase 3 invasive candidiasis study

Select another date:
Search Stocks